Portfolio Update

RNS Number : 7806C

Intl. Biotechnology Trust PLC

04 May 2012

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC

Portfolio Update

The Board of International Biotechnology Trust plc (the "Company") notes the following changes in valuations to the unquoted portfolio during April 2012:

Aptiv Solutions, a £575k increase in value to £5.62m which reflects an improvement in the company's profitability and the rating of comparable companies in the Manager's EBITDA model.

Ricerca, a £35k increase in value to £974k which reflects a slight improvement in the company's revenue and the rating of comparable companies in the Manager's revenue valuation model.

Celerion, a £458k increase in value to £735k which reflects an improvement in the company's profitability and the rating of comparable companies in an EBITDA model.

EBR Systems, a £190k decrease in value to £704k which reflects the likely valuation of the company in a new round of funding to be raised.

Allocure, a £60k decrease in value to £549k to adjust for the impact of the March 2012 fund raising on the equity of previous rounds.

Taking into account the £1.9m increase in value resulting from Jazz Pharmaceuticals acquisition of unquoted portfolio company EUSA Pharma  previously announced on Friday 27 April 2012, the impact of changes to the valuation of unquoted portfolio by the board in April 2012 was an increase of £2.7m or 4.9 pence per share.

Enquiries:

Kate Bingham/David Pinniger

Telephone: [phone]       

SV Life Sciences Managers LLP   

Investment Manager                                       

Rhona Gregg

Telephone: [phone]

BNP Paribas Secretarial Services Limited

Company Secretary

4 MAY 2012

 

END

 

 

PFUBXGDULDGBGDS